UHS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Universal Health Services Inc (UHS) is not a strong buy for a beginner, long-term investor at this time. Despite solid financial performance in the latest quarter, the technical indicators, options data, and stock trend analysis suggest bearish sentiment and potential near-term downside. The absence of significant positive catalysts and mixed analyst ratings further support a cautious approach.
The MACD is positive but contracting, suggesting weakening momentum. RSI is neutral at 36.351, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 175.701 and resistance at 187.663. Overall, the technical outlook is bearish.
The company reported strong financial performance in Q4 2025, with revenue up 9.05% YoY, net income up 34.16% YoY, and EPS up 42.34% YoY. These results demonstrate solid growth trends.
No recent news or significant insider/hedge fund activity. Analysts have mixed ratings, with some lowering price targets due to weak acute business performance. Stock trend analysis predicts a high probability of near-term price declines (-2.16% in the next day, -3.4% in the next week, -12.01% in the next month).
In Q4 2025, UHS reported revenue of $4.49 billion (+9.05% YoY), net income of $445.94 million (+34.16% YoY), and EPS of $7.06 (+42.34% YoY). Gross margin remained flat at 100%. These results indicate strong financial growth.
Analyst ratings are mixed. Guggenheim and UBS maintain Buy ratings with price targets of $238 and $320, respectively. However, Wells Fargo and Cantor Fitzgerald have Neutral/Equal Weight ratings, citing weak acute business performance. BofA maintains an Underperform rating due to policy exposure concerns.
